共 23 条
[1]
Development and characteriza-tion of an in vivo central venous catheterCandida albicansbio-film model. Andes D,Nett J,Oschel P,et al. Infection and Immunity . 2004
[2]
Antifungal activity of amphotericin B,fluconazole,and voriconazole in an in vitro model of Candida catheter-related bloodstream infec-tion. Lewis RE,DP Kontoyiannis,RO Darouiche,et al. Antimicrobial Agents and Chemotherapy . 2002
[3]
Biofilm formation by the fungal pathogenCandida albicans:development,architec-ture,and drug resistance. Chandra J,Kuhn DM,Mukherjee PK,et al. Journal of Bacteriology . 2001
[4]
Candida biofilms:an update. Gordon Ramage,Stephen P,Derek P,et al. Eukaryot Cell . 2005
[5]
cDNA mi-croarray analysis of differential gene expression inCandida albicansbiofilm exposed to farnesol. Ying-Ying Cao,Yong-Bing Cao,Zheng Xu,et al. Antimicrobial Agents and Chemotherapy . 2005
[6]
Specific antibody can pre-vent fungal biofilm formation and this effect correlates with pro-tective efficacy. Luis R,Martinez,Arturo Casadevall. Infection and Immunity . 2005
[7]
Penetration of Candida biofilms by antifungal agents. A1-Fattani MA,Douglas U. Antimicrobial Agents and Chemotherapy . 2004
[8]
Resistance ofCandida albicansbio-films to antifungal agents in vitro. Hawser SP,Douglas LG. Antimicrobial Agents and Chemotherapy . 1995
[9]
Standardized method for in vitro antifungal susceptibility testing ofCandida albicansbiofilms. Ramage G,K Vande Walle,BL Wickes,et al. Antimicrobial Agents and Chemotherapy . 2001
[10]
Mass transport of macro-molecules within an in vitro model of supragingivalplaque. Thumheer T,Gmur R,Shapiro S,et al. Applied and Environmental Microbiology . 2003